ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
12.62
+0.13 (1.00%)
Mar 31, 2025, 1:44 PM EDT - Market open
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $1.24 billion as of March 31, 2025. Its market cap has increased by 43.27% in one year.
Market Cap
1.24B
Enterprise Value
990.73M
1-Year Change
43.27%
Ranking
Category
Stock Price
$12.62
Market Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has increased from $568.25M to $1.24B, an increase of 117.82%. That is a compound annual growth rate of 38.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 1.23B | 19.53% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |